The drug infusion systems market size has grown strongly in recent years. It will grow from $14.23 billion in 2025 to $15.51 billion in 2026 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to increasing hospitalization rates, rising prevalence of chronic diseases, expansion of oncology and chemotherapy treatments, growing use of intravenous drug delivery, improved availability of infusion technologies.
The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $22.23 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing adoption of connected infusion systems, rising demand for ambulatory and homecare infusion solutions, expansion of precision drug delivery approaches, growing focus on workflow automation in hospitals, increasing investments in smart healthcare infrastructure. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising integration of dose error reduction systems, growing use of multi-channel infusion devices, expansion of home-based infusion therapies, enhanced focus on patient safety features.
The rise in healthcare expenditure is expected to drive the growth of the drug infusion systems market in the future. Healthcare expenditure refers to the total amount allocated for healthcare goods and services within a specific timeframe, usually a year. As healthcare spending increases, hospitals, clinics, and other healthcare institutions gain more resources to invest in advanced drug infusion systems, resulting in higher demand for these devices. For example, in May 2024, reports from the Office for National Statistics (ONS), a UK-based national statistical institute, indicated that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of only 0.9% in 2022. Therefore, the increase in healthcare expenditure is likely to propel the growth of the drug infusion systems market.
Leading companies in the drug infusion systems market are focusing on developing advanced technologies, such as cloud-based infusion management systems, to improve patient care, enhance accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that enable the monitoring, administration, and tracking of medication infusions via the cloud. For example, in June 2023, Eitan Medical, a U.S.-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system tailored to meet the specific needs of home and specialty infusions. Eitan Insights provides healthcare professionals with real-time data and analytics, allowing them to monitor patients remotely and adjust treatment plans as necessary. This system enhances medication safety by minimizing the risk of errors and improving adherence to prescribed protocols.
In November 2025, Biogen Inc., a US-based biotechnology company, acquired Alcyone Therapeutics for an undisclosed amount. Through this acquisition, Biogen aims to enhance its drug-delivery capabilities by integrating Alcyone’s ThecaFlex DRx implantable intrathecal system, improving patient experience and expanding access to its CNS therapies. Alcyone Therapeutics Inc., a US-based company, specializes in drug infusion systems.
Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited.
North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the drug infusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the drug infusion systems market by increasing costs of imported electronic components, sensors, precision pumps, and medical-grade plastics used in infusion devices. Hospitals and healthcare providers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are contributing to higher device procurement costs and delayed equipment upgrades. However, they are also encouraging localized manufacturing, regional supplier diversification, and increased investments in domestic medical device production capabilities.
The drug infusion systems market research report is one of a series of new reports that provides drug infusion systems market statistics, including drug infusion systems industry global market size, regional shares, competitors with a drug infusion systems market share, detailed drug infusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug infusion systems industry. This drug infusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Drug infusion systems, classified as medical devices, are instrumental in delivering medications and fluids into a patient's body through a catheter or needle. This method of administration is commonly employed in hospitals, clinics, and various healthcare settings to dispense medications such as pain relievers, antibiotics, chemotherapy drugs, and fluids to patients.
The primary categories of drug infusion systems encompass elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. Elastomeric infusion systems, for instance, are flexible containers designed to provide a consistent rate of medication delivery for short-term infusion therapy. They find application in hospitals, clinics, and home care settings for short-term drug infusion therapy. These systems are versatile, administered through various modes such as intravenous, subcutaneous, arterially, epidurally, and others. They cater to diverse medical applications, including oncology and chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and more. Various end-users, such as hospitals, ambulatory surgical centers, diagnostic centers, and others, utilize elastomeric infusion systems for their respective needs.
The drug infusion systems market consists of sales of smart pumps, syringe pumps, enteral infusion systems, and topical infusion systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $22.23 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing adoption of connected infusion systems, rising demand for ambulatory and homecare infusion solutions, expansion of precision drug delivery approaches, growing focus on workflow automation in hospitals, increasing investments in smart healthcare infrastructure. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising integration of dose error reduction systems, growing use of multi-channel infusion devices, expansion of home-based infusion therapies, enhanced focus on patient safety features.
The rise in healthcare expenditure is expected to drive the growth of the drug infusion systems market in the future. Healthcare expenditure refers to the total amount allocated for healthcare goods and services within a specific timeframe, usually a year. As healthcare spending increases, hospitals, clinics, and other healthcare institutions gain more resources to invest in advanced drug infusion systems, resulting in higher demand for these devices. For example, in May 2024, reports from the Office for National Statistics (ONS), a UK-based national statistical institute, indicated that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of only 0.9% in 2022. Therefore, the increase in healthcare expenditure is likely to propel the growth of the drug infusion systems market.
Leading companies in the drug infusion systems market are focusing on developing advanced technologies, such as cloud-based infusion management systems, to improve patient care, enhance accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that enable the monitoring, administration, and tracking of medication infusions via the cloud. For example, in June 2023, Eitan Medical, a U.S.-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system tailored to meet the specific needs of home and specialty infusions. Eitan Insights provides healthcare professionals with real-time data and analytics, allowing them to monitor patients remotely and adjust treatment plans as necessary. This system enhances medication safety by minimizing the risk of errors and improving adherence to prescribed protocols.
In November 2025, Biogen Inc., a US-based biotechnology company, acquired Alcyone Therapeutics for an undisclosed amount. Through this acquisition, Biogen aims to enhance its drug-delivery capabilities by integrating Alcyone’s ThecaFlex DRx implantable intrathecal system, improving patient experience and expanding access to its CNS therapies. Alcyone Therapeutics Inc., a US-based company, specializes in drug infusion systems.
Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited.
North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the drug infusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the drug infusion systems market by increasing costs of imported electronic components, sensors, precision pumps, and medical-grade plastics used in infusion devices. Hospitals and healthcare providers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are contributing to higher device procurement costs and delayed equipment upgrades. However, they are also encouraging localized manufacturing, regional supplier diversification, and increased investments in domestic medical device production capabilities.
The drug infusion systems market research report is one of a series of new reports that provides drug infusion systems market statistics, including drug infusion systems industry global market size, regional shares, competitors with a drug infusion systems market share, detailed drug infusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug infusion systems industry. This drug infusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Drug infusion systems, classified as medical devices, are instrumental in delivering medications and fluids into a patient's body through a catheter or needle. This method of administration is commonly employed in hospitals, clinics, and various healthcare settings to dispense medications such as pain relievers, antibiotics, chemotherapy drugs, and fluids to patients.
The primary categories of drug infusion systems encompass elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. Elastomeric infusion systems, for instance, are flexible containers designed to provide a consistent rate of medication delivery for short-term infusion therapy. They find application in hospitals, clinics, and home care settings for short-term drug infusion therapy. These systems are versatile, administered through various modes such as intravenous, subcutaneous, arterially, epidurally, and others. They cater to diverse medical applications, including oncology and chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and more. Various end-users, such as hospitals, ambulatory surgical centers, diagnostic centers, and others, utilize elastomeric infusion systems for their respective needs.
The drug infusion systems market consists of sales of smart pumps, syringe pumps, enteral infusion systems, and topical infusion systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Drug Infusion Systems Market Characteristics
3. Drug Infusion Systems Market Supply Chain Analysis
4. Global Drug Infusion Systems Market Trends and Strategies
5. Drug Infusion Systems Market Analysis of End Use Industries
7. Global Drug Infusion Systems Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Drug Infusion Systems Total Addressable Market (TAM) Analysis for the Market
9. Drug Infusion Systems Market Segmentation
10. Drug Infusion Systems Market Regional and Country Analysis
11. Asia-Pacific Drug Infusion Systems Market
12. China Drug Infusion Systems Market
13. India Drug Infusion Systems Market
14. Japan Drug Infusion Systems Market
15. Australia Drug Infusion Systems Market
16. Indonesia Drug Infusion Systems Market
17. South Korea Drug Infusion Systems Market
18. Taiwan Drug Infusion Systems Market
19. South East Asia Drug Infusion Systems Market
20. Western Europe Drug Infusion Systems Market
21. UK Drug Infusion Systems Market
22. Germany Drug Infusion Systems Market
23. France Drug Infusion Systems Market
24. Italy Drug Infusion Systems Market
25. Spain Drug Infusion Systems Market
26. Eastern Europe Drug Infusion Systems Market
27. Russia Drug Infusion Systems Market
28. North America Drug Infusion Systems Market
29. USA Drug Infusion Systems Market
30. Canada Drug Infusion Systems Market
31. South America Drug Infusion Systems Market
32. Brazil Drug Infusion Systems Market
33. Middle East Drug Infusion Systems Market
34. Africa Drug Infusion Systems Market
36. Drug Infusion Systems Market Competitive Landscape and Company Profiles
37. Drug Infusion Systems Market Other Major and Innovative Companies
40. Drug Infusion Systems Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Drug Infusion Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses drug infusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for drug infusion systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug infusion systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Elastomeric Infusion System; Disposable Infusion System; Syringe Infusion System; Peristaltic Pump; Multi-Channel Pump; Patient-Controlled Analgesia (PCA) Pump; Insulin Pump; Implantable Infusion System2) By Route Of Administration: Intravenous; Subcutaneous; Arterial; Epidural; Other Routes Of Administration
3) By Application: Oncology And Chemotherapy; Diabetes; Analgesia; Nutrition; Hematology; Pediatrics; Other Applications
4) By End User: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Other End Users
Subsegments:
1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps; Vented Elastomeric Pumps2) By Disposable Infusion System: Disposable Infusion Pumps; IV Sets With Disposable Components
3) By Syringe Infusion System: Manual Syringe Infusion Pumps; Electric Syringe Infusion Pumps
4) By Peristaltic Pump: Single-Channel Peristaltic Pumps; Multi-Channel Peristaltic Pumps
5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use; Multi-Channel Pumps For Specific Therapies
6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps; Mechanical PCA Pumps
7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps; Patch Insulin Pumps
8) By Implantable Infusion System: Implantable Pumps For Chronic Pain; Implantable Pumps For Chemotherapy
Companies Mentioned: Medtronic plc; Baxter International Inc.; B. Braun Melsungen AG; Becton Dickinson and Company; Smiths Group plc; Terumo Corporation; Fresenius SE & Co. KGaA; ICU Medical Inc.; Tandem Diabetes Care Inc.; Insulet Corporation; Ypsomed Holding AG; Abbott Diabetes Care Inc.; Flowonix Medical Inc.; Zyno Medical Inc.; IRadimed Corporation; Debiotech S.A.; Valeritas Inc.; Disetronic Medical Systems AG; Alaris Health Systems Inc.; Hospira Inc.; Mindray Medical International Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Drug Infusion Systems market report include:- Medtronic plc
- Baxter International Inc.
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Smiths Group plc
- Terumo Corporation
- Fresenius SE & Co. KGaA
- ICU Medical Inc.
- Tandem Diabetes Care Inc.
- Insulet Corporation
- Ypsomed Holding AG
- Abbott Diabetes Care Inc.
- Flowonix Medical Inc.
- Zyno Medical Inc.
- IRadimed Corporation
- Debiotech S.A.
- Valeritas Inc.
- Disetronic Medical Systems AG
- Alaris Health Systems Inc.
- Hospira Inc.
- Mindray Medical International Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 15.51 Billion |
| Forecasted Market Value ( USD | $ 22.23 Billion |
| Compound Annual Growth Rate | 9.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
